文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

可逆转的转基因表达减少同室操戈并允许 4-1BB 共刺激 CAR T 细胞靶向 T 细胞恶性肿瘤。

Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.

机构信息

Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, Texas.

Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.

出版信息

Cancer Immunol Res. 2018 Jan;6(1):47-58. doi: 10.1158/2326-6066.CIR-17-0126. Epub 2017 Oct 27.


DOI:10.1158/2326-6066.CIR-17-0126
PMID:29079655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5963729/
Abstract

T cells expressing second-generation chimeric antigen receptors (CARs) specific for CD5, a T-cell surface marker present on normal and malignant T cells, can selectively kill tumor cells. We aimed to improve this killing by substituting the CD28 costimulatory endodomain (28.z) with 4-1BB (BB.z), as 28.z CD5 CAR T cells rapidly differentiated into short-lived effector cells. In contrast, 4-1BB costimulation is known to promote development of the central memory subpopulation. Here, we found BB.z CD5 CAR T cells had impaired growth compared with 28.z CD5.CAR T cells, due to increased T-cell-T-cell fratricide. We demonstrate that TRAF signaling from the 4-1BB endodomain upregulated the intercellular adhesion molecule 1, which stabilized the fratricidal immunologic synapse between CD5 CAR T cells. As the surviving BB.z CD5 CAR T cells retained the desired central memory phenotype, we aimed to circumvent the 4-1BB-mediated toxicity using a regulated expression system that reversibly inhibits CAR expression. This system minimized CAR signaling and T-cell fratricide during expansion in the presence of a small-molecule inhibitor, and restored CAR expression and antitumor function of transduced T cells These studies reveal a mechanism by which 4-1BB costimulation impairs expansion of CD5 CAR T cells and offer a solution to mitigate this toxicity. .

摘要

表达第二代嵌合抗原受体(CAR)的 T 细胞特异性针对 CD5,这是一种存在于正常和恶性 T 细胞表面的 T 细胞表面标志物,能够选择性地杀伤肿瘤细胞。我们旨在通过用 4-1BB(BB.z)替代 CD28 共刺激内源性结构域(28.z)来改善这种杀伤作用,因为 28.z CD5 CAR T 细胞迅速分化为短暂存活的效应细胞。相比之下,4-1BB 共刺激作用已知可促进中央记忆亚群的发育。在这里,我们发现 BB.z CD5 CAR T 细胞的生长能力比 28.z CD5.CAR T 细胞受损,这是由于 T 细胞之间的自噬增加所致。我们证明,来自 4-1BB 内源性结构域的 TRAF 信号转导上调了细胞间黏附分子 1,从而稳定了 CD5 CAR T 细胞之间的自噬性免疫突触。由于存活的 BB.z CD5 CAR T 细胞保留了所需的中央记忆表型,我们旨在使用可调节表达系统来规避 4-1BB 介导的毒性,该系统可在小分子抑制剂存在的情况下可逆地抑制 CAR 表达。该系统在扩展过程中最大限度地减少了 CAR 信号和 T 细胞自噬,恢复了转导 T 细胞的 CAR 表达和抗肿瘤功能。这些研究揭示了 4-1BB 共刺激作用如何损害 CD5 CAR T 细胞的扩增,并提供了一种减轻这种毒性的解决方案。

相似文献

[1]
Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.

Cancer Immunol Res. 2017-10-27

[2]
Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.

Clin Cancer Res. 2019-7-1

[3]
In Vivo Expansion and Antitumor Activity of Coinfused CD28- and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia.

Mol Ther. 2018-2-2

[4]
Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells.

Mol Ther. 2018-3-2

[5]
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2 Breast Cancer Metastasis to the Brain.

Clin Cancer Res. 2017-10-23

[6]
2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies.

J Hematol Oncol. 2019-5-16

[7]
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model.

Cancer Immunol Res. 2017-11-27

[8]
Blocking CD38-driven fratricide among T cells enables effective antitumor activity by CD38-specific chimeric antigen receptor T cells.

J Genet Genomics. 2019-8-13

[9]
Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity.

Cell Rep Med. 2024-7-16

[10]
4-1BB enhancement of CAR T function requires NF-κB and TRAFs.

JCI Insight. 2018-9-20

引用本文的文献

[1]
Research progress on HER2-specific chimeric antigen receptor T cells for immunotherapy of solid tumors.

Front Immunol. 2025-5-21

[2]
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells.

Sci Adv. 2025-1-10

[3]
Antibody-Based Therapies for Peripheral T-Cell Lymphoma.

Cancers (Basel). 2024-10-15

[4]
Targeting T cells with tetravalent bispecific antibodies for the treatment of graft-versus-host disease.

Blood Adv. 2025-1-14

[5]
Fratricide-resistant CD7-CAR T cells in T-ALL.

Nat Med. 2024-12

[6]
CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

Sci Immunol. 2024-7-19

[7]
Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity.

Cell Rep Med. 2024-7-16

[8]
Advances in CAR-T-cell therapy in T-cell malignancies.

J Hematol Oncol. 2024-6-24

[9]
Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia.

Haematologica. 2024-6-1

[10]
Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma.

Front Oncol. 2024-4-22

本文引用的文献

[1]
Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent.

Cell Rep. 2017-10-3

[2]
Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity.

Nat Med. 2017-2

[3]
CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.

J Clin Invest. 2016-6-1

[4]
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.

Immunity. 2016-2-16

[5]
Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma.

Mol Ther. 2016-2

[6]
A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies.

Blood. 2015-8-20

[7]
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.

Nat Med. 2015-6

[8]
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.

Lancet. 2015-2-7

[9]
Chimeric antigen receptor T cells for sustained remissions in leukemia.

N Engl J Med. 2014-10-16

[10]
Design and development of therapies using chimeric antigen receptor-expressing T cells.

Immunol Rev. 2014-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索